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In Brief
Rutledge et al. used a large-scale
smartphone-based experiment to
investigate how aging affects decision-
making under uncertainty. Risk taking for
potential rewards but not losses
gradually decreased over the lifespan,
consistent with an explanation in terms of
age-related decline in the dopamine
system.
Current Biology
ReportRisk Taking for Potential Reward
Decreases across the Lifespan
Robb B. Rutledge,1,2,* Peter Smittenaar,2 Peter Zeidman,2 Harriet R. Brown,2 Rick A. Adams,2 Ulman Lindenberger,1,3,4
Peter Dayan,5 and Raymond J. Dolan1,2
1Max Planck University College London Centre for Computational Psychiatry and Ageing Research, London WC1B 5EH, UK
2Wellcome Trust Centre for Neuroimaging, University College London, London WC1N 3BG, UK
3Center for Lifespan Psychology, Max Planck Institute for Human Development, 14195 Berlin, Germany
4European University Institute, San Domenico di Fiesole, 50014 Fiesole, Italy
5Gatsby Computational Neuroscience Unit, University College London, London W1T 4JG, UK
*Correspondence: robb.rutledge@ucl.ac.uk
http://dx.doi.org/10.1016/j.cub.2016.05.017SUMMARY
The extent to which aging affects decision-making is
controversial. Given the critical financial decisions
that older adults face (e.g., managing retirement
funds), changes in risk preferences are of particular
importance [1]. Although some studies have found
that older individuals are more risk averse than
younger ones [2–4], there are also conflicting results,
and a recent meta-analysis found no evidence for a
consistent change in risk taking across the lifespan
[5]. There has as yet been little examination of one
potential substrate for age-related changes in deci-
sion-making, namely age-related decline in dopa-
mine, a neuromodulator associated with risk-taking
behavior. Here, we characterized choice preferences
in a smartphone-based experiment (n = 25,189) in
which participants chose between safe and risky
options. The number of risky options chosen in
trials with potential gains but not potential losses
decreased gradually over the lifespan, a finding
with potentially important economic consequences
for an aging population. Using a novel approach-
avoidance computational model, we found that a
Pavlovian attraction to potential reward declined
with age. This Pavlovian bias has been linked to
dopamine, suggesting that age-related decline in
this neuromodulator could lead to the observed
decrease in risk taking.
RESULTS
Risk and reward are tightly coupled, justifying the attention to
understanding risk across various fields. Pavlovian influences
are of particular significance for understanding anomalies
of choice. We recently identified one such anomaly with the
finding of a pervasive tendency to approach potential reward
and avoid potential punishments irrespective of option value
[6]. This effect is distinct from parametric decision models
based on prospect theory [7] that operationalize concepts1634 Current Biology 26, 1634–1639, June 20, 2016 ª 2016 The Auth
This is an open access article under the CC BY license (http://creativelike risk and loss aversion [8–11]. One important modulator
of appetitive Pavlovian influences is dopamine. We found
that boosting dopamine levels with levodopa (L-DOPA) dose-
dependently amplified the Pavlovian influence of potential
reward, increasing risk taking in situations with potential gains
but not losses [6]. This finding may account for why electrical
[12] and optogenetic [13, 14] stimulation of dopamine neurons
increases reward seeking and why dopamine drugs increase
risk taking [15] and pathological gambling in Parkinson’s
patients [16].
A profound change in the aging brain is a gradual decline in the
integrity of the dopamine system, corresponding to a likely func-
tional loss of dopamine. Dopamine receptor and transporter
densities decrease at rates estimated for many brain areas at
up to 10% per decade throughout the adult lifespan [17–19].
These neuromodulatory changes are linked to cognitive changes
[20–22] and changes in neural responses to reward [23–25].
Given the link between dopamine and risk taking, as well as
the critical significance of risk in financial decisions such as
saving for retirement, it becomes pressing to understand the
relationship between age and risk taking. Previous investigations
have been somewhat equivocal [5]. However, whether aging af-
fects Pavlovian influences on choice has not been previously
investigated.
We made several predictions for how decision-making under
uncertainty would be affected by aging. First, the number of
risky options chosen in trials with potential gains but not losses
would decrease with age, consistent with a finding that boosting
dopamine levels increases risk taking for potential gains but
not losses. Second, age-related decline in risk taking would
be monotonic, reflecting the gradual age-related decline in
the dopamine system. Finally, Pavlovian approach parameters
capturing a tendency to choose risky options with potential
reward would decrease with age and be more strongly associ-
ated with aging than risk-aversion parameters in standard
models. A standard clinical dose of 150mg of L-DOPA increased
choice to risky options with potential reward by 5% on average
[6]. Given this modest effect, addressing the prediction that
aging decreases risk taking for potential reward requires a sam-
ple size far greater than is typical for laboratory studies. Even a
small effect size [26] (e.g., r = 0.1) would have important eco-
nomic consequences given the large and growing elderly popu-
lation [27].ors. Published by Elsevier Ltd.
commons.org/licenses/by/4.0/).
A B C Figure 1. Task Design(A) Gain trials have only potential gains and
not potential losses. In an example gain trial, a
participant chooses between a risky option (here, a
potential reward of 95 points) and a safe option
(here, gaining 45 points). Mixed trials have both
potential gains and losses. Loss trials have only
potential losses and not potential gains.
(B) Participants self-identified into age bands, with
2,945 participants aged 50 and older.
(C) Decision reaction times increased with age
for both females and males. Error bars represent
the SEM.To test our predictions, we utilized a smartphone-based plat-
form (The Great Brain Experiment, http://www.thegreatbrain
experiment.com), freely available for Apple iOS and Google
Android systems [28–30]. We collected a dataset with a sample
size (n = 25,189) many times larger than all previous laboratory
studies on aging and decision-making under uncertainty com-
bined (meta-analysis in [5]). Participants completed a 30-trial
game in which they tried to earn points. On each trial, partici-
pants faced a choice between safe and risky options with no
time limit to make their decisions (Figure 1A; see the Experi-
mental Procedures). Risky optionswere represented by spinners
with equal probabilities for two potential outcomes, and chosen
gambles were resolved immediately. There were three types of
trials: (1) gain trials, a certain gain or a gamble with a larger po-
tential gain or zero; (2) mixed trials, zero or a gamble with a po-
tential gain or loss; and (3) loss trials, a certain loss or a gamble
with a larger potential loss or zero. Importantly, losses were not
possible in gain trials and gains were not possible in loss trials,
allowing us to dissociate effects of age on risk taking in gain
and loss domains. The average player earned 580 points (start-
ing from an endowment of 500 points), greatly exceeding the 514
points a random player earns on average. A player that always
chooses the option with the higher expected value earns 678
points on average and chooses the risky option in 54% of trials
(gain, 57%; mixed, 65%; loss, 43%). Data were analyzed for
six different age groups spanning the range of 18–69 with the
oldest group (ages 60–69) containing 931 participants (Fig-
ure 1B). As expected, median decision reaction times (Figure 1C)
increasedwith age in bothmales and females (r = 0.22, p < 0.001;
all p values were computed by permutation test; see the Exper-
imental Procedures). Participants on average chose the risky
option in 64% of trials (gain, 69%; mixed, 67%; loss, 56%).
Age-related changes in the brain have been proposed to
lead to increased noise in either value representations or choice
mechanisms [31], either of which could reduce the consistency
with which participants make the same choice when faced
with similar options on multiple occasions. Participants were
overall consistent in their choices, making the same choice
70% of the time when offered similar options in two different tri-
als (see the Supplemental Experimental Procedures). There was
no age-related change in choice consistency (r = 0.001, p > 0.1),
arguing against the theory that increased noise might lead to
more frequent errors, at least for simple economic decisions.
Next, we tested whether risk-taking behavior changed across
the lifespan, starting by examining trials with potential losses
(Figure 2A). There was a small but significant increase in risktaking in trials with both potential gains and losses (mixed trials:
r = 0.024, p < 0.001; Figure 2B). However, this change was not
monotonic, as would be expected if it resulted from gradual
age-related decline in dopamine. There was no change in risk
taking in trials with only potential losses (loss trials: r = 0.010,
p > 0.1). There was also no significant change in earnings across
the lifespan in mixed (r = 0.004, p > 0.1) and loss trials (r =
0.008, p > 0.1; Figure 2C).
By contrast, there was a substantial decline in the number of
risky choices made in gain trials, which featured potential gains
but not potential losses (Figure 2A). This age-related changewas
gradual and monotonic, with all age groups making fewer risky
choices on average than the next younger age group (all five
pair-wise comparisons, p < 0.001 by permutation test after
Bonferroni correction). This monotonicity was present in only
0.4% of 10,000 resamples (see the Experimental Procedures).
The effect size for a linear model of decline was r = 0.103
(p < 0.001; Figure 2B), significantly greater than effect sizes in
mixed or loss trials (both comparisons, p < 0.001). Furthermore,
earnings in gain trials significantly declined over the lifespan
(r = 0.045, p < 0.001; Figure 2C), suggesting that the observed
age-related changes in decision-making may have important
economic consequences. We found a similar decline in risk
taking in gain trials in both the United Kingdom (n = 10,300,
r = 0.103) and the United States (n = 2,361, r = 0.098), the
two countries for which we had sufficiently large samples. After
excluding participants in the youngest age group (who may not
yet have completed university education), we found a similar
decline in participants with (n = 11,965, r = 0.082) and without
(n = 6,194, r = 0.074) a university degree. We also found a
similar decline for Apple iOS (n = 14,305, r =0.098) and Google
Android (n = 10,884, r = 0.110) smartphones.
In a study examining the effect of pharmacologically boosting
dopamine [6], we previously described a model that included
three components: (1) loss aversion (parameter l) and risk
aversion in gain and loss domains (again and aloss) according
to established parametric models based on prospect theory
[8–11], (2) stochasticity of decision-making according to the
inverse temperature parameter (m) in the softmax equation,
and (3) Pavlovian approach-avoidance parameters applying
exclusively to gain trials (bgain) or loss trials (bloss). Boosting
dopamine affected only the Pavlovian influence of potential
reward (bgain). Based on the observation that the dopamine
system declines gradually over the lifespan, we tested the pre-
diction that this factor would underpin the observed decline in
gambling. The model-based approach permits testing which ofCurrent Biology 26, 1634–1639, June 20, 2016 1635
A B C Figure 2. Risk Taking for Potential Reward
Decreased across the Lifespan
(A) The percentage of trials in which risky
options were chosen was relatively stable for
mixed and loss trials but declined steadily
over the lifespan in gain trials. Young partici-
pants chose more risky options in gain than
mixed trials, whereas the opposite was true
for older participants. Error bars represent
the SEM.
(B) The age-related decline in risk taking in
gain trials had an effect size equal to 0.103.
Risk taking did not decrease across the life-
span in trials with potential losses (mixed or loss trials). Error bars represent bootstrapped 95% confidence intervals.
(C) Compared to the youngest age group (18–24), earnings decreased significantly with age in gain trials, but not in mixed or loss trials. Error bars represent
the SEM.the three model components (again, m, or bgain) is most strongly
associated with age.
This approach-avoidance decision model fitted choice data
from the smartphone sample (pseudo-r2 = 0.46 ± 0.25, mean ±
SD; see the Experimental Procedures) better than an established
decisionmodel based on prospect theory according to Bayesian
model comparison [32, 33] (lower Bayesian information criterion
[BIC] preferred: approach-avoidance decision model BIC =
12,737 versus prospect theory decision model BIC = 13,620).
Consistent with the observation above that choice did not
get noisier, we found that the stochasticity parameter m did
not change over the lifespan (males, r = 0.010; females, r =
0.004). Loss aversion might be expected to increase with
age, but we found, if anything, evidence for a small decrease
(males, r = 0.015; females, r = 0.026). Average loss-aversion
coefficients (males, l = 1.91; females, l = 1.85) and risk-aversion
coefficients (males, again = 0.86 and aloss = 0.70; females, again =
0.82 and aloss = 0.63) were comparable to those reported in prior
studies [4, 9].
Increasing agewas accompanied bymodest decreases in eco-
nomic risk-aversionparameters (again; Figure 3A) inbothmales (r =
0.034) and females (r =0.024). Since risk-aversion parameters
less than 1 correspond to risk aversion, these modest decreases
are consistent with the overall pattern of decreased risk taking
with age. As we predicted, there was a highly significant age-
related decrease in Pavlovian approach parameters (bgain; Fig-
ure 3B) in bothmales (r =0.090) and females (r =0.064). Effect
sizes for the relationship between bgain and age were more nega-
tive than effect sizes for again (both males and females, p < 0.001;
Figure 3C), with an average effect-size ratio inmales of 2.69 (boot-
strapped 95% confidence interval, 1.39–9.29) and an average ef-
fect-size ratio in females of 2.60 (bootstrapped 95% confidence
interval, 1.56–5.70). Thus, we find that advancing adult age is
more strongly associated with a decreased Pavlovian influence
of potential reward than a decrease in a risk-aversion parameter
of standard decision models based on prospect theory.
DISCUSSION
Normal human aging affects many cognitive abilities [22, 34].
Given the increasing size of the global elderly population, under-
standing how aging affects economic decision-making is of crit-
ical importance. Using a smartphone-based methodology, we
collected a sample (n = 25,189) much larger than that of all pre-1636 Current Biology 26, 1634–1639, June 20, 2016vious laboratory studies on decision-making under uncertainty
combined [5].We observed a substantial decrease in the number
of risky options chosen in trials with potentials gains but not
losses. We observed a preference reversal by which younger
participants were more likely to choose risky options in gain
than mixed trials and the opposite for older participants. Two
possible explanations for risk-taking changes were increased
errors or decreased risk-aversion parameters [4]. However,
aging did not affect choice consistency and had only a modest
effect on risk-aversion parameters. We recently reported that
boosting dopamine with L-DOPA increased the Pavlovian influ-
ence of potential reward [6]. Such immediate dopaminergic ef-
fects are not explained by the established role of dopamine in
learning [35–38]. Given the widespread gradual decline in the
integrity of the dopamine system across the lifespan [17–19],
we hypothesized that normal cognitive aging would reduce the
Pavlovian influence of potential reward. Using a model-based
analysis, we found that adult age is more strongly associated
with a decrease in the Pavlovian influence of potential reward
than with a decrease in risk-aversion parameters.
An ideal playerwhoalwaysselects the optionwith thehigher ex-
pected value chooses the risky option in 57% of the gain trials on
average. If economic risk-aversionparametersareequal to1,pos-
itive Pavlovian approach parameters can reduce average earn-
ings. Economic risk-aversion parameters were on average less
than 1 in all age groups, reflecting a concave utility function that
leads to risk aversion and reduced earnings. In this case, positive
Pavlovianapproachparameters can increase earnings, explaining
why age-related decreases in this parameter are associated with
decreased earnings. Whether positive Pavlovian parameters
increase or decrease earnings also depends on the available
options. If risky options in most trials are worth less than certain
alternatives, a decrease in Pavlovian parameters could actually
increase earnings. The economic implications of decreased
Pavlovian parameters depend on situations routinely faced by
older individuals.Most financial investments featurebothpotential
gains and losses. Simple economic decisions in this domain may
be suboptimal due to loss aversion but relatively unaffected by
aging. However, financial options might be presented in such a
way as to appear similar to gain trials, and in this situation older in-
dividuals might choose risky options less frequently than younger
individuals even if they yield greater returns on average.
Smartphone-based data aremore representative of the overall
population than conventional laboratory experiments [39, 40].
A B C Figure 3. Pavlovian Approach for Potential
Reward Decreased across the Lifespan
(A and B) Model fits in both females and males
showed modest declines in economic risk-aver-
sion parameters (again; A) and larger declines in
Pavlovian approach parameters (bgain; B). Error
bars represent the SEM.
(C) For both females and males, effect sizes
for age-related decline in Pavlovian approach
parameters were larger in magnitude than for
economic risk-aversion parameters. Error bars
represent bootstrapped 95% confidence intervals.
*p < 0.001.85%of users in the local university subject pool are currently uni-
versity students. In contrast, 73% of our participants are age 25
or older, and 42% report not having a university degree.
Given themany factors likely to contribute to economic prefer-
ences, addressing our hypothesis required a very large sample.
It would have been surprising to observe effect sizes larger than
those we found (r = 0.1) due to a single factor such as age-
related dopaminergic decline. In trials with potential gains and
not losses, we observed an 8% decrease in risk taking from
the youngest to the oldest age group, even larger than we antic-
ipated given the 5% increase observed in young volunteers after
taking L-DOPA [6]. Sample sizes in previous studies [5] may not
have been sufficiently large to identify age-related changes.
Task design may also play an important role in determining the
size of Pavlovian influences. Pavlovian approach parameters in
participants playing monetary lotteries were smaller than those
observed here with unpaid participants [6]. Conflicting results
reported in a recent meta-analysis [5] may reflect the varying de-
gree to which risk taking in different tasks depends on Pavlovian
influences.
In the domains of episodic memory [41] and working mem-
ory [42], pharmacological interventions with dopaminergic
drugs can restore youth-like brain activation patterns and
behavior in healthy older adults. Understanding the role of
dopamine in decision-making is particularly important when
it comes to addressing the unintended side effects of dopa-
minergic drugs, such as those commonly prescribed to indi-
viduals suffering from Parkinson’s disease, schizophrenia,
and attention deficit hyperactivity disorder. For simple eco-
nomic decisions, we found no decrease across the lifespan
in either choice consistency or risk taking for potential losses.
This selective pattern of changes is hard to reconcile with
general explanations unrelated to normal cognitive aging, such
as cohort differences in familiarity with computerized games.
However, this pattern of results is fully consistent with an expla-
nation in terms of age-related dopaminergic decline. At the
population level, knowing the specific choice situations in
which aging does and does not affect decision-making may
be useful for policymakers, and the existence of these age-
related changes in behavior may have important economic
consequences.
EXPERIMENTAL PROCEDURES
Participants
We tested 25,189 participants (aged 18–69, 11,951 male) who completed the
task between May 1, 2013 and September 1, 2014. All participants gaveinformed consent, and the Research Ethics Committee of University College
London approved the study.
Smartphone-Based Experiment
Participants completed 30 choice trials and rated their happiness 12 times,
typically in 3–5 min. An analysis of happiness responses has been reported
previously [29]. Consistent with previous research [43], happiness increased
with age (Supplemental Experimental Procedures). Each play consisted of
11 gain, 8 mixed, and 11 loss trials (Supplemental Experimental Procedures).
Data Analysis
We analyzed the first play from each participant (Supplemental Experimental
Procedures). We report Pearson correlation coefficients for effect sizes of re-
lationships between task measures and age. All p values were computed
based on permutation tests using 10,000 random shuffles of age labels to
determine null distributions. Bootstrapped 95% confidence intervals were
computed based on 10,000 resamples with replacement in each age or age/
gender group. We fitted choices in individual participants with an approach-
avoidance decision model [6]. As in common parametric decision models
[4, 8–11], subjective values or utilities were determined as follows:
Ugamble = 0:5

Vgain
again  0:5lðVlossÞaloss ;
Ucertain = ðVcertainÞagain if VcertainR0;
and
Ucertain =  lð  VcertainÞaloss if Vcertain < 0;
where Vgain and Vloss are the potential gain and loss from a gamble, respec-
tively, and Vcertain is the certain option value. Choice probabilities are
commonly determined by the softmax rule:
Pgamble =
1
1+ emðUgambleUcertainÞ
;
where the inverse temperature parameter m quantifies choice stochasticity.We
modified this equation to permit choice probabilities that differ from 0 or 1 in
the limit. For gain trials, gambling probability was determined by bgain:
Pgamble =

1 bgain

1+ emðUgambleUcertainÞ
+ bgain if bgainR0
and
Pgamble =

1+ bgain

1+ emðUgambleUcertainÞ
if bgain < 0:
Model parameters were fit by the method of maximum likelihood in individ-
ual participants, and we used Bayesian model comparison techniques [32, 33]
to compare model fits.
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